Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...

Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...